CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,411 enrolled
Drug / intervention
Choice of TIV or FluMist with baseline advertisement +2 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00808808
NCT00808808N/ACompleted
CompareCT.gov

Assessing Choice in the Employer Setting (ACES Study): An Observational Study to Assess the Impact of Offering Intranasal Vaccine on Influenza Vaccination Rates in the Employer Setting

MedImmune LLC·observational·Posted Dec 16, 2008·Updated Nov 20, 2013

In Brief

An observational study evaluating Choice of TIV or FluMist with baseline advertisement, Choice of TIV or FluMist with enhanced advertisement and incentives, and 1 other intervention for Healthy. Completed, enrolled 4,411 participants across 47 sites.

Detailed Summary

The purpose of this study is to determine, among adults and in the total population, the effects of offering a choice of FluMist or trivalent inactivated vaccine (TIV) in the employer setting when compared to a control group.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsPassport Health, University of Pittsburgh

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 16, 2008
Enrollment StartSep 1, 2008
Primary CompletionNov 1, 2008
Study CompletionDec 1, 2008
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 17.5 years ago

Interventions

Choice of TIV or FluMist with baseline advertisementbiological

An intervention arm offering choice of TIV or FluMist with baseline advertisement, including advertisement to highlight the availability of FluMist

Choice of TIV or FluMist with enhanced advertisement and incentivesother

An intervention arm offering choice of TIV or FluMist with enhanced advertisement and additional incentives for receiving an influenza vaccination

Control - Usual care offering TIV only with baseline advertisementbiological

A control arm of usual care offering TIV with baseline advertisement